Stop Meth Labs and Enhance Patient Access Act of 2014

Bill: 113-hr-4502
Sponsor: full_name: Rep. Luetkemeyer, Blaine [R-MO-3]
Introduced: 2014-04-28
Policy area: Crime and Law Enforcement
Subjects: Business records

Drug trafficking and controlled substances

Government information and archives

Prescription drugs

Retail and wholesale trades
Latest action: action_date: 2014-06-09
text: Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Summaries:
action_date: 2014-04-28
action_desc: Introduced in House
text: <p>Stop Meth Labs and Enhance Patient Access Act of 2014 - Amends the Controlled Substances Act to authorize the Attorney General to exempt a scheduled listed chemical product from specified requirements regarding sales quantity, nonliquid forms, and retail transactions upon determining that it is not practical by processes known to be employed by clandestine laboratory operators to use the product in the illicit manufacture of methamphetamine (currently, upon determining that the product cannot be used in the illicit manufacture of methamphetamine).</p>

tv_txt: I 113th CONGRESS 2d Session H. R. 4502 IN THE HOUSE OF REPRESENTATIVES April 28, 2014 Mr. Luetkemeyer introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To authorize the Attorney General to exempt certain products from the requirements of subsections (d) and (e) of section 310 of the Controlled Substances Act if it is not practical to use such products in the illicit manufacture of methamphetamine.

1. Short title This Act may be cited as the Stop Meth Labs and Enhance Patient Access Act of 2014 . 2. Exemption if it is not practical to use product in illicit manufacture of methamphetamine Section 310(e)(3) of the Controlled Substances Act ( 21 U.S.C. 830(e)(3) ) is amended by striking if the Attorney General determines that the product cannot be used in the illicit manufacture of methamphetamine and inserting if the Attorney General determines that it is not practical by processes known to be employed by clandestine laboratory operators to use the product in the illicit manufacture of methamphetamine .